ArticleBMJ open2013

A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing.

Ingunn Fride Tvete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.